Atrial fibrillation and Chronic Kidney Disease stage 5
Conditions
Brief summary
Ischemic stroke and systemic embolism (composite)
Detailed description
Composite event of intracranial bleeding (including hemorrhagic stroke) and fatal bleeding, Hospitalization for myocardial infarction, cardiovascular intervention, or cardiovascular death (composite), All-cause death, All-cause stroke or systemic embolism, Major bleeding (as defined in the International Society on Thrombosis and Haemostasias (ISTH) consensus)
Interventions
DRUGApixaban Accord 2.5 mg film-coated tablets
Sponsors
Karolinska University Hospital, Medical University Of Silesia Katowice Poland
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ischemic stroke and systemic embolism (composite) | — |
Secondary
| Measure | Time frame |
|---|---|
| Composite event of intracranial bleeding (including hemorrhagic stroke) and fatal bleeding, Hospitalization for myocardial infarction, cardiovascular intervention, or cardiovascular death (composite), All-cause death, All-cause stroke or systemic embolism, Major bleeding (as defined in the International Society on Thrombosis and Haemostasias (ISTH) consensus) | — |
Countries
Finland, Iceland, Netherlands, Norway, Poland, Sweden
Outcome results
None listed